Global Pharmaceuticals & Biotech Potentially Undervalued Companies

Sumitomo Pharma

Market Cap: JP¥969.8b

Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

Telix Pharmaceuticals

Market Cap: AU$5.0b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Shanghai Junshi Biosciences

Market Cap: HK$36.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

HUTCHMED (China)

Market Cap: HK$1.8b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Livzon Pharmaceutical Group

Market Cap: CN¥29.5b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

Jazz Pharmaceuticals

Market Cap: Mex$10.3b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥11.9b

Engages in the blood product businesses in China.

Nanjing Vazyme Biotech

Market Cap: CN¥8.7b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

GNI Group

Market Cap: JP¥129.5b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Duality Biotherapeutics

Market Cap: HK$29.7b

A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Square Pharmaceuticals

Market Cap: ৳179.7b

Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.

Johnson & Johnson

Market Cap: €487.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Vitrolife

Market Cap: SEK 19.1b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Vetoquinol

Market Cap: €884.7m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Evotec

Market Cap: €962.2m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Bristol-Myers Squibb

Market Cap: R$105.8b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

United Therapeutics

Market Cap: €20.8b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Bayer

Market Cap: €32.8b

Operates as a life science company worldwide.

CureVac

Market Cap: €1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Magle Chemoswed Holding

Market Cap: SEK 359.3m

Engages in research and development of pharmaceutical and medical device products in Sweden.

H. Lundbeck

Market Cap: DKK 42.4b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Organon

Market Cap: €1.9b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Geron

Market Cap: €810.7m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

hVIVO

Market Cap: UK£34.0m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Sarepta Therapeutics

Market Cap: €2.4b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Genmab

Market Cap: US$125.2b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Beijing Tong Ren Tang Chinese Medicine

Market Cap: €7.6b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

Haleon

Market Cap: €32.1b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

United Laboratories International Holdings

Market Cap: €25.5b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Merck KGaA

Market Cap: €52.5b

Operates as a science and technology company in Germany and internationally.

Novo Nordisk

Market Cap: €1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Inotiv

Market Cap: US$30.2m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

H. Lundbeck

Market Cap: €42.4b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Novartis

Market Cap: €205.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

HUTCHMED (China)

Market Cap: US$1.8b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.0b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.